Latest Breaking News On - Charles theuer - Page 1 : comparemela.com

TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Q1 2024 Earnings Call Transcript

TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

Charles-theuer
Jim-molloy
Matt-venezia
Matthew-venezia
James-molloy
Scott-brown
Johnson
Alliance-global-partners
Pharmaceuticals-first-quarter
Hearings-panel
Nasdaq

TRACON to Report First Quarter 2024 Financial Results and Provide Corporate Update on May 14, 2024

TRACON to Report First Quarter 2024 Financial Results and Provide Corporate Update on May 14, 2024
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

United-states
Charles-theuer
Brian-ritchie
Company-contact
Lifesci-advisors

TRACON Pharmaceuticals Announces Reverse Stock Split

SAN DIEGO, April 08, 2024 (GLOBE NEWSWIRE) TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company utilizing a.

United-states
Charles-theuer
Brian-ritchie
Lifesci-advisors
Company-the-board
Company-contact
Product-development-platform
Exchange-commission
Company-board
Equiniti-trust-company
Restated-certificate
Nasdaq-capital-market

TRACON Pharmaceutical (TCON) Provides Positive Update on Ongoing ENVASARC Pivotal Phase 2 Trial

TRACON Pharmaceutical (TCON) Provides Positive Update on Ongoing ENVASARC Pivotal Phase 2 Trial
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

China
United-states
Chinese
America
Charles-theuer
Tracon-pharmaceuticals
Drug-administration
Alphamab-oncology

TRACON Pharmaceutical (TCON) Announces ENVASARC Phase 2 Pivotal Trial Exceeded Futility Threshold at Final Interim Analysis and Will Continue as Planned

TRACON Pharmaceutical (TCON) Announces ENVASARC Phase 2 Pivotal Trial Exceeded Futility Threshold at Final Interim Analysis and Will Continue as Planned
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Charles-theuer
Tracon-pharmaceuticals
James-freddo